Japanese Journal of Clinical Immunology
Online ISSN : 1349-7413
Print ISSN : 0911-4300
ISSN-L : 0911-4300
Case Reports
Psoriasiform eruption induced by adalimumab in a patient with rheumatoid arthritis : a case report and review of literature
Haruna KUNOTakuya KOTANITohru TAKEUCHIDaisuke WAKURAReiko WAKURAAkitoshi YUShigeki MAKINOShinichi MORIWAKIToshiaki HANAFUSA
Author information
JOURNAL FREE ACCESS

2012 Volume 35 Issue 6 Pages 520-525

Details
Abstract
  A 72-year-old man developed arthritis of the bilateral shoulders and fingers. X-ray examination of the fingers showed periarticular osteoporosis, joint space narrowing, and cystic changes at the bone ends. Because contrast-enhanced MRI revealed synovial membrane proliferation and osteolysis, a diagnosis of rheumatoid arthritis (RA) was made. Treatment for RA with methotrexate (4 mg/week) was initiated in December 2008. In February 2009, adalimumab administration (40 mg/2 weeks) was initiated. The RA markedly improved, and clinical remission was maintained thereafter. However, in April 2010, relatively well-delineated erythematous plaques accompanied by bullae and scales developed on the bilateral palms, toes, limbs, and the inguinal region. A diagnosis of psoriasis-like eruptions was made by skin biopsy, and adalimumab administration was discontinued. After 4 months, the eruptions improved. Psoriasis-like eruptions due to anti-TNF drugs are rarely observed, but adverse effects require caution. This case is reported along with a review of the literature.
Content from these authors
© 2012 The Japan Society for Clinical Immunology
Previous article Next article
feedback
Top